MTM Quality Metrics & Outcome Assessment 4 — Questions and Answers
Question 1: A pharmacy's Part D plan reports a medication adherence triple-weighted star measure. This weighting means that:
- The measure is counted three times in calculating the overall star rating (Correct answer)
- Three separate adherence measures are averaged into one score
- Patients must be adherent for three consecutive years
- The measure applies to three drug classes simultaneously
Correct answer: The measure is counted three times in calculating the overall star rating
Triple-weighted measures count three times in the overall star calculation, making adherence measures among the most influential on a plan's composite rating.
Question 2: An MTM program measures 'all-cause 30-day hospital readmissions.' The primary limitation of this metric for assessing MTM impact is:
- It requires physician authorization to collect
- Many readmissions are unrelated to medication-related problems MTM can address (Correct answer)
- It is not endorsed by any quality accreditation body
- Readmission rates cannot be calculated from pharmacy claims
Correct answer: Many readmissions are unrelated to medication-related problems MTM can address
All-cause readmissions include admissions for trauma, surgery, or conditions unrelated to medication management, diluting the signal attributable to MTM interventions.
Question 3: In a run chart used to track monthly MTM CMR completion rates, a 'signal' indicating a non-random shift is defined as:
- Any single data point above the median
- Six or more consecutive data points on the same side of the median (Correct answer)
- A data point exceeding two standard deviations
- Three consecutive months with declining rates
Correct answer: Six or more consecutive data points on the same side of the median
Run chart rules define a signal (non-random pattern) as six or more consecutive points on the same side of the median, suggesting a true process change.
Question 4: The Ambulatory Care Quality Alliance (AQA) pharmacy quality measures focus primarily on:
- Inpatient medication reconciliation rates
- Ambulatory prescription appropriateness and adherence (Correct answer)
- Emergency department prescribing patterns
- Long-term care facility medication error rates
Correct answer: Ambulatory prescription appropriateness and adherence
AQA pharmacy quality measures are designed to assess appropriate prescribing, safety, and adherence in ambulatory outpatient settings.
Question 5: A pharmacist calculates that 65% of her MTM patients achieved their LDL-C goal of <70 mg/dL after 6 months. This is an example of which type of outcome?
- Process outcome
- Intermediate clinical outcome (Correct answer)
- Humanistic outcome
- Economic outcome
Correct answer: Intermediate clinical outcome
LDL-C is a biomarker (surrogate endpoint) that represents an intermediate clinical outcome, sitting between process (statin use) and true clinical events (MI, stroke).
Question 6: When an MTM pharmacist identifies a drug-drug interaction between warfarin and fluconazole and recommends dose adjustment, the resulting quality metric most directly affected is:
- Medication adherence for cholesterol medications
- High-risk medication use in elderly patients
- Drug-drug interaction resolution rate (Correct answer)
- Proportion of days covered for anticoagulants
Correct answer: Drug-drug interaction resolution rate
Identifying and resolving drug-drug interactions is directly captured by drug-drug interaction resolution rate, a core MTM process and safety quality metric.
Question 7: Which NCQA HEDIS measure specifically addresses appropriate medication management in patients with asthma?
- Asthma Medication Ratio (AMR)
- Medication Management for People with Asthma (MMA) (Correct answer)
- Controller Medication Adherence for Asthma
- Asthma Controller Prescription Fill Rate
Correct answer: Medication Management for People with Asthma (MMA)
HEDIS Medication Management for People with Asthma (MMA) measures the percentage of members with persistent asthma who were dispensed appropriate controller medications.
MTM Quality Metrics & Outcome Assessment 4
A pharmacy's Part D plan reports a medication adherence triple-weighted star measure.
This weighting means that: